ACCESS TO AFFORDABLE PRESCRIPTIONS FOR LOW-INCOME PATIENTS
“My office will not stand idly by while [drug makers] prioritize profits over access to affordable prescription medications and other critical medical services for vulnerable communities. Therefore, I urge [Eli Lilly, Astra Zeneca, Merck, Sanofi, and Novartis] to abandon [their] unilateral and unlawful actions,” Attorney General Tong states in the letters. The 340B Drug Pricing Program requires drug manufacturers to provide discounted drugs to eligible health centers and hospitals, including community health centers, nonprofit and public hospitals, and Ryan White HIV/AIDS clinics. The facilities can either directly provide discounted drugs to low-income patients, or contract with pharmacies to dispense the drugs at a discount. Since 1992, the 340B Drug Pricing Program has been a lifeline to low-income patients and community-based health…
